cohort_drift

TL3 Regular · Oxford, UK

Long-standing member. Posts carefully and infrequently, mostly in the practice and analytics categories.

Joined 26 July 2024 · last posted 5d

159 posts, newest first. Showing up to 150.

I joined for one answer and stayed for a year — what changed my mind Replied, post #103 · Start Here › Welcome · 23 Jul 2026 · 12 likes Same experience here, different supplier, so it is at least not unique to one of them.
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #82 · Compounds › Retatrutide · 21 Jul 2026 · 25 likes Where I part company with post #80, and it is a narrow parting. Retatrutide discussion was covered in the wiki last year and the page has a review date on it, which is…
Journal club: LEADER as the historical anchor Replied, post #107 · Evidence › Journal club · 20 Jul 2026 · 9 likes Picking up post #104: that is the part I would want checked first. The documentation on LEADER is better than this thread and I say that as someone who has posted in…
Research-use-only status: what it means legally and practically Replied, post #78 · Compounds › Other compounds · 20 Jul 2026 · 0 likes One more thing on research-use-only status that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the…
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #65 · Practice › Interactions · 20 Jul 2026 · 7 likes Delayed gastric emptying is the mechanism behind most of the plausible interactions in this class: anything whose absorption depends on how quickly the stomach empties…
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #58 · Clinical › Bloodwork · 18 Jul 2026 · 0 likes A trend needs at least three points to be a trend. Two points are a line and a line through noise is still a line. That has been true for the cases I have seen and I…
Primary endpoint hierarchies and why order matters — one year on Replied, post #50 · Evidence › Trials · 17 Jul 2026 · 8 likes Open-label design: unblinded trials admit expectation effects. For weight-loss trials where one arm loses substantial weight and the other does not, complete blinding…
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #87 · Practice › Interactions · 17 Jul 2026 · 7 likes On post #83 — agreed on the reasoning, with one qualification. Supplements and herbs: many have no established interaction. Some do. If you are taking something…
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #68 · Practice › Dosing & titration · 16 Jul 2026 · 26 likes I read post #64 twice before replying, because I had assumed the opposite. Half steps are arithmetically simple and pharmacologically unstudied. They are not dangerous…
Revisiting: How this community labels and discusses unrefereed work Replied, post #23 · Evidence › Preprints · 13 Jul 2026 · 0 likes Reading a preprint properly means doing some of the reviewer's job: methods first, then whether the analysis matches the plan, then the conclusion. None of the above is…
How shortages have affected compounding permissions Replied, post #27 · Access › Shortages · 10 Jul 2026 · 0 likes One caution on shortages: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is rarely stated.
Preservatives: function, testing, and limits — one year on Replied, post #30 · Pharmacology › Formulation chemistry · 9 Jul 2026 · 3 likes Sterility and stability are separate properties requiring separate controls. A preservative addresses one of them and nothing about the other. That is a description of…
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #27 · Compounds › Retatrutide · 8 Jul 2026 · 2 likes Where I part company with post #23, and it is a narrow parting. A request rather than an answer: could whoever has the primary source for glucagon receptor agonist post…
Micro-titration: a disputed topic, argued properly Replied, post #101 · Practice › Dosing & titration · 7 Jul 2026 · 12 likes Adding the measurement that post #100 says would settle it. Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long…
Prior authorisation: what the criteria usually require — a second dataset Replied, post #3 · Access › Insurance & coverage · 5 Jul 2026 · 7 likes Narrowing the opening post, because the general version has more than one answer. The most useful reply I ever got about Prior authorisation was a request to state my…
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #48 · Clinical › Comorbidities · 30 Jun 2026 · 22 likes Building on post #45 rather than restating it. If you are new and reading this thread for the answer to PCOS and metabolic overlap: the answer is conditional, the…
Journal club: what we got wrong in an earlier session Replied, post #41 · Evidence › Journal club · 30 Jun 2026 · 26 likes Reading rather than contributing, but this is the most useful thread I have found on it.
What steady state means for the decision to escalate Replied, post #21 · Practice › Dosing & titration · 29 Jun 2026 · 0 likes The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is off-label by definition. Some people compute it anyway. The…
Journal club: what we got wrong in an earlier session Replied, post #34 · Evidence › Journal club · 27 Jun 2026 · 14 likes A session that ends with a list of what remains unresolved is more useful than one that ends with a verdict. The unresolved list is what feeds the next reading.
I joined for one answer and stayed for a year — what changed my mind Replied, post #45 · Start Here › Welcome · 27 Jun 2026 · 0 likes The compound and evidence pages are updated regularly and they are worth reading when you are new. They answer the meta questions like "do we have data on this" and…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #99 · Practice › Reconstitution · 26 Jun 2026 · 4 likes Taking post #98 at face value and following it one step further. Add the diluent down the side of the vial rather than directly onto the cake. It is slower and it…
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #48 · Analytics › HPLC & UHPLC · 24 Jun 2026 · 2 likes Post #45 answers the question as asked. The question underneath it is different. Gradient delay volume differs between instruments and shifts the whole chromatogram. It…
Tracking a shortage from primary sources rather than rumour Replied, post #66 · Access › Shortages · 23 Jun 2026 · 1 like This follows post #64 rather than contradicting it. Shortage-driven price movement is real and is a separate question from availability. I am aware this is the third…
Alcohol: what is documented and what is folklore Replied, post #50 · Practice › Interactions · 10 Jun 2026 · 19 likes If someone has run alcohol properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.
Comparing documentation quality across the directory, tabulated Replied, post #5 · Sourcing › Vendor reports · 9 Jun 2026 · 0 likes I had read the opposite somewhere and cannot now find where, which tells me something.
HbA1c lag and what it can and cannot tell you at eight weeks — one year on Replied, post #9 · Clinical › Bloodwork · 8 Jun 2026 · 20 likes The arithmetic in post #7 is right; the assumption feeding it is the part to check. A trend needs at least three points to be a trend. Two points are a line and a line…
Asking a follow-up: new topic or new reply? Replied, post #3 · Start Here › How to Ask · 6 Jun 2026 · 11 likes That is clearer than the version I had in my head. Thank you.
Revisiting: Body image changing more slowly than the body Replied, post #6 · Wellbeing › Mental health · 4 Jun 2026 · 31 likes Relationship with food changing is one of the most commonly described experiences here and is discussed far less than the physical effects. Nothing above should be read…
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #54 · Safety › Contraindications · 29 May 2026 · 0 likes Somebody's condition being on a list does not settle the decision, and somebody's condition being absent from one does not either. Worth saying I have only my own…
Prescription requirements and telehealth models — a second dataset Replied, post #36 · Sourcing › Regulatory · 20 May 2026 · 30 likes This follows post #33 rather than contradicting it. A definition problem is doing most of the work in this Prescription requirements and telehealth models discussion.…
The headache that turns out to be dehydration — the long version Replied, post #37 · Nutrition & Training › Hydration & electrolytes · 18 May 2026 · 6 likes Symptoms attributed to electrolytes here are non-specific and overlap with dehydration, low intake and poor sleep. Attribution from symptoms alone is unreliable. That…
Why this subcategory is stricter about sourcing than most Replied, post #31 · Compounds › Secretagogues & GH axis · 18 May 2026 · 0 likes Injection-site reactions are reported more often in this family than for the incretins. Whether that is the compounds or the preparations they are typically supplied in…
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #119 · Devices › Syringes & needles · 14 May 2026 · 0 likes Reading rather than contributing, but this is the most useful thread I have found on it.
Why we ask for units every single time, with three examples of what goes wrong — what… Replied, post #7 · Start Here › How to Ask · 11 May 2026 · 27 likes Nothing to add, except that this is the answer I would give if asked.
Converting between mg/mL and units per dose, both directions — the long version Replied, post #54 · Practice › Reconstitution · 21 Apr 2026 · 17 likes On post #52 — agreed on the reasoning, with one qualification. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a…
Does a peptide degrade silently, with no visual change? Replied, post #13 · Practice › Storage & stability · 20 Apr 2026 · 0 likes Adding the measurement that post #10 says would settle it. Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or…
[2026 update] Regional warehouse stock versus direct despatch Replied, post #42 · Sourcing › Logistics · 14 Apr 2026 · 1 like What I can speak to on Regional warehouse stock versus direct is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
Shoulders, tangent skims, and defensible integration — the long version Replied, post #20 · Analytics › HPLC & UHPLC · 10 Apr 2026 · 14 likes A relative retention time against a known peak travels much better than an absolute one, and almost nobody reports it. I would put a moderate confidence on that and no…
Reference intervals: how they are constructed and why one in twenty flags Replied, post #76 · Clinical › Bloodwork · 6 Apr 2026 · 0 likes Glycaemic markers integrate over different periods. A point glucose and a longer-term marker disagreeing is not a contradiction; it is two different questions.
Follow-up: Search filters: what is missing Replied, post #69 · Meta › Site feedback · 4 Apr 2026 · 22 likes Distinguishing three things in the Search filters discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the recommendation…
Publication bias detection and its low power — does this still hold? Replied, post #20 · Evidence › Meta-analyses · 28 Mar 2026 · 0 likes Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be…
Grapefruit: why this class is not the class that cares Replied, post #66 · Practice › Interactions · 22 Mar 2026 · 2 likes Picking up post #65: that is the part I would want checked first. I disagree with the framing of grapefruit above, and I think it is a substantive disagreement rather…
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #106 · Clinical › Bloodwork · 20 Mar 2026 · 7 likes If you are new and reading this thread for the answer to panel: the answer is conditional, the conditions are in the third reply, and the rest of the thread is worth…
Grapefruit: why this class is not the class that cares Replied, post #31 · Practice › Interactions · 11 Mar 2026 · 19 likes This is the sort of exchange that makes the archive worth searching.
Choosing which test to pay for, given a fixed budget Replied, post #18 · Sourcing › Independent verification · 9 Mar 2026 · 5 likes Building on post #15 rather than restating it. Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the…
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #135 · Compounds › Semaglutide · 4 Mar 2026 · 24 likes On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already does that. There is no published interaction study…
Trifluoroacetate content and its consequences Replied, post #40 · Analytics › Impurities & related substances · 28 Jan 2026 · 1 like Post #36 describes the usual case. This is about the unusual one. Dimer and higher-order multimers: two or more peptide molecules bonded together. They appear at double…
Second pass at: The topic list is dense — is that deliberate? Replied, post #56 · Meta › Site feedback · 28 Jan 2026 · 0 likes What I want from this topic list thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can check it.
Warfarin and altered intake: the monitoring argument — the long version Replied, post #95 · Practice › Interactions · 22 Jan 2026 · 24 likes Coming back to post #94, because the follow-up matters more than the original answer. The strongest argument against my own position on Warfarin and altered intake,…
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #27 · Data & Tools › Calculators · 20 Jan 2026 · 8 likes Tools that run entirely in the browser send nothing anywhere, which matters more to some people here than others and is worth stating either way. It is one reading of…
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #91 · Compounds › Semaglutide · 11 Jan 2026 · 3 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
A partial dose because the pen emptied mid-injection Replied, post #101 · Practice › Administration · 10 Jan 2026 · 10 likes Two sentences on partial dose because the pen and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is narrow.…
Reading U-100 graduations, with a conversion table — one year on Replied, post #2 · Devices › Syringes & needles · 6 Jan 2026 · 12 likes Reading units correctly: look at the marking from the side, not from above or below. The bottom of the plunger tip is the reading. Parallax error (wrong angle) is a…
Second pass at: Metformin co-administration and additive GI effects Replied, post #27 · Practice › Interactions · 2 Jan 2026 · 22 likes Adding the measurement that post #24 says would settle it. For anyone finding this later: the short answer on Metformin co-administration is that it depends on one…
When to stop reading forums, including this one Replied, post #70 · Wellbeing › Mental health · 2 Jan 2026 · 27 likes Nothing here is medical advice and several members in this subcategory say plainly that they are describing their own experience only. I am describing what is, rather…
Why a compound being unapproved is not the same as being illegal to possess Replied, post #42 · Sourcing › Regulatory · 19 Dec 2025 · 13 likes Bookmarking this. I will come back when I have something worth adding.
Why "add 2 mL" is not an instruction Replied, post #18 · Practice › Reconstitution · 16 Dec 2025 · 0 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
Publishing an inconvenient result: a case study — the long version Replied, post #71 · Sourcing › Independent verification · 15 Dec 2025 · 26 likes That matches what I have seen, for whatever a single anecdote is worth.
CJC-1295 with and without DAC: what the modification does — what changed since Replied, post #2 · Compounds › Secretagogues & GH axis · 29 Nov 2025 · 0 likes Useful. I had the fact and not the reason, which turns out to be the important half.
History of disordered eating and why it changes the conversation Replied, post #24 · Clinical › Special populations · 25 Nov 2025 · 6 likes Narrowing post #22, because the general version has more than one answer. Speaking only to history of disordered eating as I have actually seen it, rather than as it is…
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #65 · Compounds › Oral incretins · 24 Nov 2025 · 0 likes Post #63 describes the usual case. This is about the unusual one. The gastrointestinal tolerability profile of the oral formulation is broadly similar in character to…
What a purity-only report leaves out Replied, post #95 · Sourcing › Independent verification · 20 Nov 2025 · 23 likes Following this. I have the same question and no better information than the first post.
"Greater than or equal to 99%" as a specification rather than a result Replied, post #71 · Analytics › COA interpretation · 15 Nov 2025 · 15 likes Asking for the batch record rather than the certificate is a reasonable request and the response to it is informative whichever way it goes. If this contradicts…
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #28 · Documentation › Doc review · 7 Nov 2025 · 7 likes Narrowing post #26, because the general version has more than one answer. Ask what the page would look like if it were wrong. A document with no stated failure…
[2026 update] What steady state means for the decision to escalate Replied, post #14 · Practice › Dosing & titration · 5 Nov 2025 · 21 likes Answering the question post #11 raises rather than the one it answers. Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a…
A parcel that arrived warm: a decision process, not a verdict Replied, post #119 · Practice › Storage & stability · 3 Nov 2025 · 0 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear. Worth reading the…
A parcel that arrived warm: a decision process, not a verdict Replied, post #106 · Practice › Storage & stability · 27 Oct 2025 · 6 likes Good question, well framed, and I would like to see it answered properly.
How to read a forest plot, properly, from scratch Replied, post #45 · Evidence › Trials · 24 Oct 2025 · 3 likes I read post #41 twice before replying, because I had assumed the opposite. Composite endpoints should be read component by component. A composite driven entirely by its…
Reconciling a supplier certificate with an independent result Replied, post #11 · Sourcing › Vendor reports · 21 Oct 2025 · 18 likes If the supplier was asked about a discrepancy, include what they said verbatim rather than summarised. The wording of a response is informative.
Documentation that appears only after payment Replied, post #54 · Sourcing › Red flags · 20 Oct 2025 · 1 like The version of documentation that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
Second pass at: The mass-error checker and its intended scope Replied, post #39 · Data & Tools › Calculators · 15 Oct 2025 · 0 likes Post #36 describes the usual case. This is about the unusual one. For anyone finding this later: the short answer on mass-error checker is that it depends on one thing,…
Follow-up: Constipation management, with a dietitian's contribution Replied, post #4 · Practice › Side effects · 15 Oct 2025 · 2 likes Picking up post #3: that is the part I would want checked first. The number people quote for Constipation management is a central estimate presented without its…
The headache that turns out to be dehydration Replied, post #10 · Nutrition & Training › Hydration & electrolytes · 30 Sep 2025 · 25 likes Vomiting and diarrhoea lose fluid and electrolytes together, and replacing only fluid is what turns a short illness into a longer problem. If anyone has run this…
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #78 · Devices › Cold chain · 18 Sep 2025 · 19 likes I would be cautious about generalising from the Airline travel example above. It is a good example. It is one example.
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #125 · Evidence › Study critique · 16 Sep 2025 · 16 likes A methods point on Reverse causation rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the difference in method.
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #118 · Evidence › Study critique · 16 Sep 2025 · 2 likes The arithmetic in post #117 is right; the assumption feeding it is the part to check. Filing a mild objection to the consensus on Reverse causation. Mild because I…
Thyroid function tests during substantial weight change Replied, post #60 · Clinical › Bloodwork · 13 Sep 2025 · 4 likes The arithmetic in post #57 is right; the assumption feeding it is the part to check. I disagree with the framing of thyroid function tests during substantial above, and…
Follow-up: The decimal-point error, and the habit that catches it Replied, post #56 · Practice › Reconstitution · 8 Sep 2025 · 24 likes Decimal-point error was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #33 · Analytics › Method validation · 5 Sep 2025 · 3 likes Reading this LOD and LOQ thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #118 · Practice › Reconstitution · 3 Sep 2025 · 22 likes A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some preservatives crystallise in cold), is the vial being warmed gently…
Guidelines revision: what changed and why — one year on Replied, post #11 · Meta › Announcements · 28 Aug 2025 · 0 likes Worth saying publicly: stepping back cleanly and handing over is a service. Documents with an absent maintainer go wrong quietly, which is the worst way for them to go…
Follow-up: Why appetite effects are mostly central Replied, post #27 · Pharmacology › Receptor biology · 28 Aug 2025 · 14 likes What would change my mind on appetite effects is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say…
Tirzepatide molecular mass and the charge states you would expect on ESI Replied, post #23 · Compounds › Tirzepatide · 27 Aug 2025 · 21 likes The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on satiety and energy expenditure, but how much of tirzepatide's effect is that and how…
Coming back to: Lurking for two months before posting: was that the right call? Replied, post #31 · Start Here › Welcome · 26 Aug 2025 · 2 likes The category structure looks heavier than it is. There are twenty top-level categories and you will use three of them. Find those three, mute the rest for a month, and…
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #87 · Compounds › Oral incretins · 22 Aug 2025 · 3 likes Adding the measurement that post #86 says would settle it. The SOUL trial: cardiovascular outcomes trial for oral semaglutide in people with type 2 diabetes and…
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #47 · Practice › Side effects · 22 Aug 2025 · 5 likes Pancreatitis: a rare but serious event with a specific presentation (epigastric pain, back pain, elevated lipase). If this constellation of findings appears, stopping…
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #82 · Evidence › Journal club · 21 Aug 2025 · 32 likes Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything…
Asking about a compound your prescriber has not heard of Replied, post #132 · Clinical › Prescriber conversations · 20 Aug 2025 · 10 likes Post #131 answers the question as asked. The question underneath it is different. Bringing a record of symptoms with dates and severities makes an assessment materially…
Realistic expectations for strength while losing weight quickly Replied, post #14 · Nutrition & Training › Resistance training · 16 Aug 2025 · 0 likes Post #12 is the version of this I will quote in future. One addition. Deload weeks: periodic weeks (every 4 to 8 weeks) with reduced volume and intensity can help with…
Hypertension improvement and when medication needs revisiting Replied, post #8 · Clinical › Comorbidities · 14 Aug 2025 · 31 likes A history of pancreatitis appears in the cautions for this class and the decision around it is one that needs a clinician who knows the history. Two people can read the…
Enforcement priorities versus written rules — does this still hold? Replied, post #4 · Sourcing › Regulatory · 9 Aug 2025 · 5 likes Coming back to post #2, because the follow-up matters more than the original answer. Import rules for personal quantities differ from commercial import rules and both…
A request that was declined, and the reasoning — a second dataset Replied, post #32 · Documentation › Wiki requests · 8 Aug 2025 · 0 likes A request that says what the page should not cover is unusually helpful, because scope creep is what kills these. I have kept the units in throughout, for the obvious…
Are there stupid questions here? A staff answer, at length Replied, post #44 · Start Here › Welcome · 6 Aug 2025 · 1 like Welcome. The orientation materials are pinned at the top of this category and they take about an hour. They answer most of the questions a new member has and they save…
Publishing an inconvenient result: a case study Replied, post #61 · Sourcing › Independent verification · 5 Aug 2025 · 2 likes That is the distinction I keep failing to hold on to. Written down now.
Travel coolers and how long they really hold Replied, post #21 · Devices › Cold chain · 1 Aug 2025 · 0 likes Insulation performance depends on the mass of the coolant more than on the thickness of the box. A large pack in a modest box outperforms a small pack in a good one.…
Are there stupid questions here? A staff answer, at length Replied, post #31 · Start Here › Welcome · 1 Aug 2025 · 33 likes If you want a fast orientation, read three solved topics in the subcategory you care about. Solved means somebody said the answer worked, which is more signal than…
A preprint whose numbers changed substantially at publication Replied, post #6 · Evidence › Preprints · 30 Jul 2025 · 0 likes Confirming post #3 from a second method, which matters more than confirming it from a second person. Say it is a preprint in the first line rather than the last.…
IGF-1 as a surrogate endpoint and its limitations — the long version Replied, post #16 · Compounds › Secretagogues & GH axis · 26 Jul 2025 · 7 likes CJC-1295 with and without DAC: the version with a drug affinity complex binds albumin covalently and persists for days. The version without it does not persist.…
Journal club: STEP 8 and the fairness of the comparator dose Replied, post #4 · Evidence › Journal club · 24 Jul 2025 · 7 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #4 · Compounds › Secretagogues & GH axis · 21 Jul 2025 · 7 likes Bookmarking this. I will come back when I have something worth adding.
What this community means by "a source", in practical terms Replied, post #39 · Start Here › Welcome · 19 Jul 2025 · 6 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
A field-by-field walk through a certificate of analysis Replied, post #135 · Analytics › COA interpretation · 18 Jul 2025 · 0 likes Taking post #134 at face value and following it one step further. A certificate of analysis is a statement by its issuer that a defined test was performed on a defined…
Immortal time bias in a claims-database study Replied, post #2 · Evidence › Study critique · 17 Jul 2025 · 14 likes Second-hand on immortal time bias, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself.
Why the timeline is on the right and not the left Replied, post #41 · Meta › Site feedback · 15 Jul 2025 · 1 like Last piece of feedback: the site is much better on a narrow screen than it was six months ago and nobody said so at the time. Recording it because only the failures…
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #140 · Devices › Cold chain · 11 Jul 2025 · 1 like Building on post #137 rather than restating it. A temperature indicator that has tripped tells you a threshold was crossed. It does not tell you for how long, and…
Ipamorelin selectivity claims and where they came from Replied, post #55 · Compounds › Secretagogues & GH axis · 9 Jul 2025 · 14 likes Confirming post #52 from a second method, which matters more than confirming it from a second person. Ipamorelin is usually described as selective in that it produces…
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #36 · Compounds › Cagrilintide & amylin analogues · 9 Jul 2025 · 30 likes Taking post #35 at face value and following it one step further. Amylin signalling is distinct from GLP-1 signalling. Amylin slows gastric emptying and promotes satiety…
Interpreting a composition change that is within the error bars Replied, post #12 · Outcomes › Body composition · 6 Jul 2025 · 7 likes Comparing a body composition result against a population reference is a different exercise from tracking your own change, and the second is what most people want.…
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #52 · Evidence › Journal club · 24 Jun 2025 · 4 likes I have no financial interest in anything named in this thread and I want to say so before I comment on CagriSema phase 2 combination paper, because it is the sort of…
Preparing for an appointment: one page, three questions Replied, post #23 · Clinical › Prescriber conversations · 16 Jun 2025 · 0 likes Asking about the plan if the first approach does not work is a good use of an appointment and is rarely done.
Why plausible mechanism is not evidence of effect Replied, post #15 · Compounds › Repair & healing peptides · 12 Jun 2025 · 12 likes If you are new and reading this thread for the answer to plausible mechanism: the answer is conditional, the conditions are in the third reply, and the rest of the…
Half-life, steady state, and accumulation worked through Replied, post #83 · Pharmacology › Pharmacokinetics · 8 Jun 2025 · 11 likes Washout after stopping takes roughly the same four to five half-lives as reaching steady state. A month after the last dose is not the same as none.
Follow-up: History of disordered eating and why it changes the conversation Replied, post #20 · Clinical › Special populations · 7 Jun 2025 · 22 likes The arithmetic in post #17 is right; the assumption feeding it is the part to check. Whatever the answer on History of disordered eating turns out to be, the method for…
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #8 · Access › Insurance & coverage · 5 Jun 2025 · 2 likes Post #6 put the caveat in the right place and I want to underline it. I disagree with the framing of Reading a denial letter above, and I think it is a substantive…
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #128 · Compounds › Cagrilintide & amylin analogues · 5 Jun 2025 · 7 likes Post #126 describes the usual case. This is about the unusual one. Anyone submitting this for independent testing should say in the submission that it is an amylin…
Half-life, steady state, and accumulation worked through Replied, post #62 · Pharmacology › Pharmacokinetics · 4 Jun 2025 · 0 likes The honest answer on half-life is that it depends, and the useful part is the list of what it depends on. Four items, in rough order of how much they matter. Most…
Second pass at: Trial registration and comparing the protocol with the paper Replied, post #8 · Evidence › Trials · 1 Jun 2025 · 6 likes Post #6 put the caveat in the right place and I want to underline it. Safety findings from a trial powered for efficacy are underpowered by construction. Absence of a…
"Should I double up?" — answered once, at length, calmly Started this topic · Practice › Administration · 30 May 2025 · 13 likes "Should I double up?" — answered once, at length, calmly — setting out what I have, and where I think it stops being reliable. A practical question that I suspect has a…
Albumin binding and how it produces a long half-life Replied, post #40 · Pharmacology › Pharmacokinetics · 25 May 2025 · 2 likes The failure mode on albumin binding is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple to get…
Antibiotics and a course of something with delayed emptying Replied, post #45 · Practice › Interactions · 20 May 2025 · 11 likes For anyone finding this later: the short answer on antibiotics is that it depends on one thing, and the rest of the thread is people identifying which thing.
A well-designed study with a badly written abstract Replied, post #68 · Evidence › Study critique · 8 May 2025 · 0 likes Where I part company with post #64, and it is a narrow parting. Well-designed study was covered in the wiki last year and the page has a review date on it, which is a…
Follow-up: What other technical communities get right that we do not Replied, post #88 · Lounge › Off topic · 5 May 2025 · 0 likes Non-technical and offered in the right category: the best thing about a forum with no vote score is that the boring accurate answer sits at the same level as the…
Scheduled maintenance and what will be unavailable Replied, post #81 · Meta › Announcements · 21 Mar 2025 · 28 likes Answering the question post #79 raises rather than the one it answers. Two questions I would want answered before drawing anything from the scheduled maintenance data…
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #27 · Compounds › Tirzepatide · 19 Mar 2025 · 0 likes Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent and partly because the clinical programme used a…
One lot is one lot: when a report becomes a pattern — the long version Replied, post #20 · Sourcing › Vendor reports · 15 Mar 2025 · 17 likes Reports of ordinary results are more valuable than reports of remarkable ones, precisely because only the remarkable ones get posted elsewhere.
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #6 · Evidence › Journal club · 4 Mar 2025 · 10 likes On post #4 — agreed on the reasoning, with one qualification. STEP 4 sits at the boundary between what this community can usefully discuss and what it cannot, and I…
Validating a method you did not develop — does this still hold? Replied, post #64 · Analytics › Method validation · 2 Mar 2025 · 0 likes This follows post #61 rather than contradicting it. A method transferred between laboratories needs a demonstration that it performs equivalently, not just a document…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #30 · Compounds › Tirzepatide · 1 Mar 2025 · 0 likes The five maintenance doses in the tirzepatide programme give a genuine dose-response curve, which is unusual. Most trials in this space compare one or two doses against…
Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #8 · Evidence › Journal club · 23 Feb 2025 · 7 likes Nothing to add, except that this is the answer I would give if asked.
Protein density versus volume when you cannot eat much Replied, post #102 · Nutrition & Training › Protein & intake · 10 Feb 2025 · 7 likes Protein sources: animal sources (meat, fish, eggs, dairy) are denser and easier to hit targets with. Plant sources require higher volume. Neither is nutritionally…
UK access routes, dated and sourced — a second dataset Replied, post #34 · Regional › UK & Ireland · 3 Feb 2025 · 12 likes Cross-border movement between the two jurisdictions is not the same as domestic movement within either, and the rules are published rather than inferred. If anyone has…
Protein density versus volume when you cannot eat much Replied, post #5 · Nutrition & Training › Protein & intake · 22 Jan 2025 · 18 likes The useful distinction on protein density versus volume is between what was measured and what was inferred from it. Both end up in the same sentence and only one of…
What we do not know about retatrutide, listed explicitly Replied, post #65 · Compounds › Retatrutide · 22 Jan 2025 · 31 likes Heart rate increased in a dose-dependent way in the phase 2 work. That is not a footnote — it is one of the specific things phase 3 exists to characterise, and it is…
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #42 · Compounds › Oral incretins · 12 Jan 2025 · 22 likes The arithmetic in post #39 is right; the assumption feeding it is the part to check. PIONEER 6 is the cardiovascular outcome trial for oral semaglutide and it enrolled…
[2026 update] New subcategory: rationale and scope Replied, post #138 · Meta › Announcements · 11 Jan 2025 · 16 likes The thing about New subcategory that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look, not a result.
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #122 · Compounds › Oral incretins · 28 Dec 2024 · 0 likes What I would check first on Oral semaglutide bioavailability is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in…
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #2 · Compounds › Repair & healing peptides · 26 Dec 2024 · 11 likes Two claims get bundled together under BPC-157 and they need separating. The descriptive one — this is what was observed — is usually well supported. The causal one —…
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #91 · Compounds › Semaglutide · 24 Dec 2024 · 0 likes One more thing on Molecular mass of semaglutide that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice…
Converting between mg/mL and units per dose, both directions Replied, post #129 · Practice › Reconstitution · 14 Dec 2024 · 9 likes I read post #128 twice before replying, because I had assumed the opposite. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither…
A promotion I argued against, and why I lost Replied, post #29 · Documentation › Doc review · 14 Dec 2024 · 0 likes Reviewing your own nomination is fine and is not sufficient. Somebody else has to read it for the process to mean anything. That is the honest state of it as of this…
Individual participant data versus aggregate data Replied, post #10 · Evidence › Meta-analyses · 7 Dec 2024 · 6 likes No disagreement from me. Posting only so the question does not look ignored.
What changed in 2026, by region Replied, post #7 · Access › International · 3 Dec 2024 · 8 likes Taking post #4 at face value and following it one step further. Regional practice around what a pharmacy will and will not do varies enormously and is not deducible…
Washout with a one-week half-life: the arithmetic Replied, post #26 · Research Methods › N-of-1 designs · 27 Nov 2024 · 0 likes Multiple outcomes measured without a primary one means something will move. Nominate the primary in advance and report the rest as secondary. Happy to be corrected if…
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #48 · Compounds › Tirzepatide · 21 Nov 2024 · 0 likes SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did not compare with semaglutide 2.4 mg, the highest approved dose.…
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Started this topic · Data & Tools › Calculators · 19 Nov 2024 · 10 likes Revisiting: Bug report: the reconstitution calculator and a rounding edge case — setting out what I have, and where I think it stops being reliable. Posting the…
Coming back to: Grapefruit: why this class is not the class that cares Replied, post #28 · Practice › Interactions · 19 Nov 2024 · 0 likes The practical version of Grapefruit is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions attached.
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #16 · Practice › Reconstitution · 17 Nov 2024 · 14 likes I read post #12 twice before replying, because I had assumed the opposite. On a U-100 insulin syringe, one hundred units is one millilitre and one unit is 0.01…
How to ask for a dose change without antagonising anyone — what changed since Replied, post #52 · Clinical › Prescriber conversations · 11 Nov 2024 · 17 likes A question phrased as "what would you want to see before considering X" is answerable and is not a request for X.
Time to steady state after a dose increase Replied, post #97 · Pharmacology › Pharmacokinetics · 5 Nov 2024 · 1 like Post #95 describes the usual case. This is about the unusual one. Between-person variability in exposure is substantial and is the reason two people on the same dose…
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #90 · Clinical › Bloodwork · 8 Oct 2024 · 33 likes Reading this bring a laboratory thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.